ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1757

Quantitative Assessment of Synovial Vascularity Using Power Doppler Index in Rheumatoid Arthritis and Psoriatic Arthritis Patients with High Disease Activity

Michał Jakubaszek, Maria Maślińska and Brygida Kwiatkowska, National Institute of Geriatrics Rheumatology and Rehabilitation, Warsaw, Poland

Meeting: ACR Convergence 2023

Keywords: Disease Activity, Psoriatic arthritis, rheumatoid arthritis, Synovitis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1734–1775) RA – Etiology and Pathogenesis Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Usefulness of quantitative assessment of synovial vascularity in ultrasound (US) imaging in patients with active RA and PsA (peripheral arthritis). Additionally the assessment of vascularity index (INDEX%) dependency on immunological markers such as rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) were assessed.The last aim of the study was to examine whether patients with high active peripheral PsA differ in the severity of synovial congestion from patients with high RA activity.

Methods: A total of n=80 patients were included into the study, n=60 with RA and n=20 PsA. Majority of them (for both group) were female (n=53.66.25%). Laboratory variables were assessed: RF (IU/ML units), ACPA (U/ML), ESR (mm/hour) and C-reactive protein (CRP;MG/L); disease activity were assessed by DAS 28(ESR) and simplified disease activity score (SDAI). The power doppler US (PDUS) was performed with assessment of a) the degree of the synovial membrane vascularization (from 0 to 4 grade); the following scores were used in the assessment: 0- no signs of synovial flow, 1- isolated signals in hypertrophied synovium, 2-vessels occupy less than 50% of hypertrophied membrane area synovitis, 3- inflammation affects over 50% of the examined area; b) vascularity index measured by PDUS index (INDEX%) in the ROI (region of interest) frame (figure 1). All patients underwent examination using the same US machine and by the same specialist in radiology and imaging diagnostics.

Results: Disease activity for RA and PsA patients was between 4.8- 8.3 with DAS28 and 23-183 with SDAI. The hypothesis of a positive correlation between the concentration of ACPA and INDEX% in RA group was confirmed however it was a week positivity(r=0.26) but such correlation between RF and INDEX% was not confirmed (r=0.03). ESR, CRP, DAS 28(ESR) and SDAI did not correlate significantly with the value of INDEX%. What was expected the strong positivity (r=0.56) was between SDAI and DAS28 results. Interestingly there was no correlation between DAS 28, SDAI and INDEX %, probably because all of patients from both groups had high disease activity.

Conclusion: Positive correlation between the concentration of ACPA and INDEX% value indicating that ACPA may be a prognostic factor for vascularization of the synovial membrane in patients with RA. No such correlation was confirmed for RF. Taken together obtained results pointed to ACPA as more important for synovial inflammatory activity in RA. Vascularity of synovial membrane assesed by INDEX %compared between RA and PsA group was equally high, despite the difference in RF and ACPA indicating that the presence of other cytokines is more involved in the development of synovial inflammation in PsA. The quantitative US assessment of synovial vascularity is a useful tool in comparative studies and may have a significant advantage over a qualitative study after expanding the study groups with different degrees of inflammatory activity in the synovium.

Supporting image 1

Synovial membrane with active inflammation (vascularization) and region of interest frame indicated.


Disclosures: M. Jakubaszek: None; M. Maślińska: None; B. Kwiatkowska: None.

To cite this abstract in AMA style:

Jakubaszek M, Maślińska M, Kwiatkowska B. Quantitative Assessment of Synovial Vascularity Using Power Doppler Index in Rheumatoid Arthritis and Psoriatic Arthritis Patients with High Disease Activity [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/quantitative-assessment-of-synovial-vascularity-using-power-doppler-index-in-rheumatoid-arthritis-and-psoriatic-arthritis-patients-with-high-disease-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-assessment-of-synovial-vascularity-using-power-doppler-index-in-rheumatoid-arthritis-and-psoriatic-arthritis-patients-with-high-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology